|
⚲
|
| Keyboard |
| Lynch Regenerative Medicine LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002008439 |
| Sale | 2026-06-30 (17.5 M Offered, 15.0 M Sold) |
| Fund | |
| Phone | 6156494694 |
| Address | 302 Innovation Drive Franklin, TN 37067 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-15 (D) |
| Exemption | 506(b) |
| Remaining | $2,500,000 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Andrea Dini | Executive Officer | |
| Tod Reed | Director | |
| Earl Douglas | Director | |
| Allison Lynch | Director | |
| Samuel Lynch | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Avondale Partners LLC
✚
|
TN | |
|
Patten Group Inc
✚
|
TN | |
|
Patten & Patten Inc/TN
✚
|
TN | |
|
Greater Sum Ventures Capital LLC
✚
|
TN | |
|
SSN Advisory Inc
✚
|
TN | |
|
Capwealth Insights LLC
✚
|
TN | |
|
Gavion LLC
✚
|
TN | |
|
Abound Wealth Management
✚
|
TN | |
|
Rinehart Capital Partners LLC
✚
|
TN | |
|
Kingswell Capital Management LLC
✚
|
TN |